ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Enantioselective Access to Trifluoromethylated Spirocyclopropyl Heterocycles.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Chiral spirocyclopropyl heterocycles have emerged as privileged three-dimensional structural motifs in medicinal chemistry. Nevertheless, efficient catalytic enantioselective assembly of such compounds still faces considerable synthetic difficulties. Herein, we describe a rhodium-mediated asymmetric [2+1] cyclopropanation reaction using methylene azacycles and fluoroalkyl triftosylhydrazones as reaction partners, which offers a concise synthetic route toward enantioenriched trifluoromethylated spirocyclopropyl heterocyclic derivatives. This synthetic transformation tolerates various substrates and functional groups, and achieves remarkable stereochemical control. Multiple spirocyclic skeletons can be efficiently constructed with favorable yields and prominent diastereo- and enantioselectivity, with the highest e.e. value recorded at 99%. The acquired spirocyclopropyl oxazolidinone derivatives can be further derivatized via internal reactive moieties, which allows their integration into bioactive molecular frameworks. By combining fluoroalkyl carbenes with asymmetric spirocyclopropanation, the present work develops a general catalytic system to synthesize elusive fluoroalkyl-bearing chiral spirocyclopropyl heterocycles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.